ChemicalBook > Product Catalog >Analytical Chemistry >Reference Substance >(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile

(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile

(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile Suppliers list
Company Name: Moxin Chemicals
Tel: +86-17320513646 +8617320513646
Email: anna@molcoo.com
Products Intro: Product Name:Tofacitinib Impurity TBA
CAS:1640971-60-3
Purity:95 Package:100mg;|50mg;|30mg
Company Name: Standardpharm Co. Ltd.
Tel: 86-714-3992388
Email: overseasales1@yongstandards.com
Products Intro: Product Name:Tofacitinib Impurity 18
CAS:1640971-60-3
Purity:0.99 Package:10mg;25mg;50mg;100mg
Company Name: career henan chemical co
Tel: +86-0371-86658258 +8613203830695
Email: factory@coreychem.com
Products Intro: Product Name:(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile
CAS:1640971-60-3
Purity:98% Package:1KG;6.6USD
Company Name: ANHUI WITOP BIOTECH CO., LTD
Tel: +8615255079626
Email: eric@witopchemical.com
Products Intro: Product Name:Tofacitinib Related Compound 11
CAS:1640971-60-3
Purity:99% Package:1kg
Company Name: CR Corporation Limited
Tel: +8613062833949
Email: fred.wen@crcorporation.cn
Products Intro: Product Name:tofacitinib iMpurity
CAS:1640971-60-3

(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile manufacturers

(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile Basic information
Product Name:(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile
Synonyms:ofacitinib iMpurity;Tofacitinib Citrate Impurity;tofacitinib iMpurity;Tofacitinib Impurity 11;3-((3R,4R)-3-((6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl) (methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate-one;Tofacitinib Impurity TBA;Tofacitinib Impurity 5 DiHCl;N2,N4-bis((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N2,N4-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine
CAS:1640971-60-3
MF:C14H20N6O
MW:288.35
EINECS:
Product Categories:ZJ;ZY
Mol File:1640971-60-3.mol
(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile Structure
(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile Chemical Properties
Melting point 238 - 240°C
Boiling point 551.0±50.0 °C(Predicted)
density 1.249±0.06 g/cm3(Predicted)
storage temp. Refrigerator
solubility Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
pka6.06±0.60(Predicted)
form Solid
color White to Off-White
Safety Information
MSDS Information
(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile Usage And Synthesis
UsesTofacitinib Citrate Impurity is derived from (3R,4R)-N,4-Dimethyl-1-benzyl-3-piperidinamine (D464895), which is a reagent used in the preparation of Janus tyrosine kinase inhibitors for the treatment of autoimmune diseases.
(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile Preparation Products And Raw materials
Tag:(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile(1640971-60-3) Related Product Information
Tofacitinib related coMpound 2 3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine Dapagliflozin iMpurity LUMACAFTOR IMPURITY Tenofovirdisoproxil Impurity Sulbactam Impurity Sildenafil Aldehyde IMpurity Piperacillin Impurity Rocuronium Bromide Impurity Sorafenib IMpurity 7-(4-Hydroxybutoxy-4,4-d2)-2(1H)-quinolinone (1R,3S)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester BENZOOXAZOL-2-YLAMINE 2-Bromo-2-(2-fluorophenyl)-1-cyclopropylethanone Etoricoxib IMpurity